Sign In  |  Register  |  About San Anselmo  |  Contact Us

San Anselmo, CA
September 01, 2020 1:33pm
7-Day Forecast | Traffic

  • Search Hotels in San Anselmo

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Latest News about ABBV

Recent news which mentions ABBV

< Previous 1 2 3 4 5 6 7 8 9
...
32 33 Next >
Comparing AbbVie With Industry Competitors In Biotechnology Industry
Tickers ABBV NEWS
Tags News ABBV Trading Ideas
From Benzinga
Behind the Scenes of AbbVie's Latest Options Trends
Tickers ABBV
Tags Markets Market News BZI/UOA
From Benzinga
Medicare Drug Price Negotiation Program Gets Final Guidance For Second Cycle, $1.5B Savings Expected
Tickers ABBV GSK NEWS NVO
Tags General Biotech Stories That Matter
From Benzinga
5 Best Dividend Growth Stocks to Buy in October
Tickers ABBV AXP BAC COST
Tags AXP COST BAC
From Motley Fool
Meta, Accenture, Disney And A Major Health Care Stock On CNBC's 'Final Trades'
Tickers ABBV ACN DIS META
Tags News Trading Ideas ABBV
From Benzinga
(ABBV) - Analyzing AbbVie's Short Interest
Tickers ABBV
Tags Trading Ideas Benzinga ABBV
From Benzinga
Absence of Black Box Warning For Bristol Myers' Schizophrenia Treatment Could Enhance Alzheimer's Psychosis Potential
Tickers ABBV BMY NEWS
Tags General Benzinga Movers
From Benzinga
Here's How Much You Would Have Made Owning AbbVie Stock In The Last 10 Years
Tickers ABBV NEWS
Tags BZI/POD Market News News
From Benzinga
AbbVie Says Pivotal Trial For Parkinson's Candidate Meets Its Primary Goal In Patients With Early Disease
Tickers ABBV NEWS
Tags ABBV Health Care Top Stories
From Benzinga
Forget Novo Nordisk, Buy This Magnificent Dividend Stock Instead
Tickers ABBV NVO
Tags ABBV NVO Recent Press Releases
From Motley Fool
Behind the Scenes of AbbVie's Latest Options Trends
Tickers ABBV
Tags Market News Markets Options
From Benzinga
Bristol-Myers Acquired Drug KarXT Poised For FDA Approval As First New Type Of Schizophrenia Treatment In 70 Years
Tickers ABBV BMY NEWS
Tags Benzinga Stories That Matter Biotech
From Benzinga
Spotlight on AbbVie: Analyzing the Surge in Options Activity
Tickers ABBV
Tags Benzinga Options ABBV
From Benzinga
Competitor Analysis: Evaluating AbbVie And Competitors In Biotechnology Industry
Tickers ABBV NEWS
Tags Market News Markets ABBV
From Benzinga
2 Unstoppable S&P 500 Dividend Stocks to Buy Before They Beat the Market Again
Tickers ABBV AZN
Tags Recent Press Releases Market News ABBV
From Motley Fool
TransDigm, BJ's Wholesale, AbbVie And More On CNBC's 'Final Trades'
Tickers ABBV BJ NEWS SMH
Tags BJ CNBC TDG
From Benzinga
Can AbbVie Regain Its Status As a Top Dividend Growth Stock?
Tickers ABBV ABT
Tags ABT ABBV Market News
From Motley Fool
Investing in Biotech or Pharma Stocks? Pay Attention to These 3 Things and You'll Win More
Tickers ABBV MRNA
Tags MRNA ZLDP/F ABBV
From Motley Fool
3 Stocks to Buy and Hold Forever
Tickers ABBV ABT LLY VRTX
Tags Market News Recent Press Releases ABBV
From Motley Fool
Want Decades of Passive Income? 3 Stocks to Buy Now and Hold Forever
Tickers ABBV BIP BIPC VZ
Tags ABBV Recent Press Releases BIP
From Motley Fool
Is This Company Still a Strong Buy After Tripling the S&P 500's Returns?
Tickers ABBV
Tags ABBV Market News Recent Press Releases
From Motley Fool
UnitedHealth Follows Competitors, Replaces Humira with Lower-Cost Biosimilars
Tickers ABBV ALVO AMGN CI
Tags Media General UNH
From Benzinga
< Previous 1 2 3 4 5 6 7 8 9
...
32 33 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 SanAnselmo.com & California Media Partners, LLC. All rights reserved.